أناستروزول
| Kind | API |
|---|---|
| Class | Endocrine oncology — non-steroidal aromatase inhibitor |
| Synonyms | ZD-1033 |
| Common uses / forms | Film-coated tablets 1 mg; postmenopausal ER-positive breast cancer |
| Properties | Low-dose (1 mg) high-potency triazole aromatase inhibitor; only moderately/sparingly water-soluble in absolute terms but BCS high-solubility on the 1 mg dose, high permeability (BCS Class I); essentially a single stable crystalline form |
| Compendia | USP, EP, BP, IP |
| Sourcing origins | India, China |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$$ (> $1000 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | High-potency hormone — OEB containment; low dose makes assay and content uniformity the key formulation risk. |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Anastrozole — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-anastrozole.html